SignatureFD’s Gossamer Bio GOSS Stock Holding History

SignatureFD’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-182	Closed	-$395	–	3325
2022 Q4	$395	Sell	182 -95	-34%	-$782	﹤0.01%	3130
2022 Q3	$3K	Buy	277 +65	+31%	+$807	﹤0.01%	2639
2022 Q2	$2K	Buy	+212	New	+$1.64K	﹤0.01%	2744

Other funds holding GOSS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

SignatureFD's GOSS Position: Q1 2023 in Review

SignatureFD sold out of Gossamer Bio (GOSS) in Q1 2023, closing a stake of 182 shares — an estimated $395 sold.

SignatureFD first reported a position in GOSS in Q2 2022 and held it in 3 quarters. The position peaked at $3K in Q3 2022. 111 funds tracked by Wall St. Rank hold GOSS as of Q1 2023.

SignatureFD reported no remaining Gossamer Bio position as of Q1 2023 after selling out during the quarter.
SignatureFD sold 182 Gossamer Bio shares in Q1 2023, an estimated $395.
SignatureFD first reported a position in Gossamer Bio in Q2 2022 and held it in 3 quarters.
SignatureFD's Gossamer Bio position peaked at $3K in Q3 2022.
111 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2023.

Based on SignatureFD's 13F filing for Q1 2023, filed 28 Apr 2023.